MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/07/2022 inter alia to consider and approve the proposal for buyback of fully paid up equity shares of the Company upto such amount of the aggregate of Companys paid up equity share capital and free reserves as the Board may decide in accordance with the provisions of Section 68 69 and 70 of the Companies Act 2013 and the SEBI (Buyback of Securities) Regulations 2018.It is further submitted that in terms of the Companys Code of Conduct to Regulate Monitor and Report Trading by designated persons framed pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended the trading window for dealing in the shares of the Company for the designated person(s) is already closed w.e.f. July 01 2022 and will remain closed till 48 hours after the declaration of unaudited financial results for the quarter ended June 30 2022.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
